These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37995969)

  • 1. Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease.
    Chen X; Xiao J; Tao D; Liang Y; Chen S; Shen L; Li S; Zheng Z; Zeng Y; Luo C; Peng F; Long H
    Transl Res; 2024 Apr; 266():68-83. PubMed ID: 37995969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
    Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
    Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
    [No Abstract]   [Full Text] [Related]  

  • 3. Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice.
    Lv Z; Hu M; Fan M; Li X; Lin J; Zhen J; Wang Z; Jin H; Wang R
    Cell Death Dis; 2018 Mar; 9(3):342. PubMed ID: 29497040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
    Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
    J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria.
    Zhou L; Chen X; Lu M; Wu Q; Yuan Q; Hu C; Miao J; Zhang Y; Li H; Hou FF; Nie J; Liu Y
    Kidney Int; 2019 Apr; 95(4):830-845. PubMed ID: 30770219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
    Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
    FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin.
    Alquraishi M; Chahed S; Alani D; Puckett DL; Dowker PD; Hubbard K; Zhao Y; Kim JY; Nodit L; Fatima H; Donohoe D; Voy B; Chowanadisai W; Bettaieb A
    Cell Commun Signal; 2022 May; 20(1):76. PubMed ID: 35637461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/β-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria.
    Jiang L; Xu L; Song Y; Li J; Mao J; Zhao AZ; He W; Yang J; Dai C
    J Biol Chem; 2013 Aug; 288(32):23368-79. PubMed ID: 23803607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
    Zhou D; Wang Y; Gui Y; Fu H; Zhou S; Wang Y; Bastacky SI; Stolz DB; Liu Y
    Kidney Int; 2022 Jul; 102(1):96-107. PubMed ID: 35341792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
    Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
    J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metadherin facilitates podocyte apoptosis in diabetic nephropathy.
    Liu WT; Peng FF; Li HY; Chen XW; Gong WQ; Chen WJ; Chen YH; Li PL; Li ST; Xu ZZ; Long HB
    Cell Death Dis; 2016 Nov; 7(11):e2477. PubMed ID: 27882943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
    He W; Kang YS; Dai C; Liu Y
    J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
    Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
    Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubular injury triggers podocyte dysfunction by β-catenin-driven release of MMP-7.
    Tan RJ; Li Y; Rush BM; Cerqueira DM; Zhou D; Fu H; Ho J; Beer Stolz D; Liu Y
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31743113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celastrol attenuates diabetic nephropathy by upregulating SIRT1-mediated inhibition of EZH2related wnt/β-catenin signaling.
    Tang Y; Wan F; Tang X; Lin Y; Zhang H; Cao J; Yang R
    Int Immunopharmacol; 2023 Sep; 122():110584. PubMed ID: 37454630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Exacerbates Podocyte Injury and the Progression of Diabetic Kidney Disease.
    Qu H; Gong X; Liu X; Zhang R; Wang Y; Huang B; Zhang L; Zheng H; Zheng Y
    Diabetes; 2021 Jun; 70(6):1372-1387. PubMed ID: 33741719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.
    Zhou L; Liu Y
    Nat Rev Nephrol; 2015 Sep; 11(9):535-45. PubMed ID: 26055352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway.
    Miao H; Wang YN; Su W; Zou L; Zhuang SG; Yu XY; Liu F; Zhao YY
    Acta Pharmacol Sin; 2024 Jan; 45(1):137-149. PubMed ID: 37640899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.